App launched to help detect UTIs

Newfoundland Diagnostics have collaborated with the Rightdose Self-Test and Treat App to provide an at-home test and treat service for those who test positive for urinary tract infections (UTIs). 

The process for patients involves ordering a UTI test, then using the QR code on the box to download and register with the Rightdose Test and Treat App. Patients perform the test, verify the results and, if positive, update the App, select medication and pay, with medication expected to arrive to the person’s door in 24 hours. 

This service, in addition to what GP surgeries and high street pharmacies offer, is designed to alleviate pressure on the NHS, particularly for individuals who would prefer to manage UTIs from the comfort of their own home, perhaps because they are a family carer or need to get treatment for a family member with dementia.  

The Rightdose Self-Test and Treat kit is here: https://www.rightdose.co.uk/medications/uti-self-test-and-treat-kit/ (cost from £15). 

Prompt treatment of UTI’s is important, with NHS England highlighting last October that in the past five years there have been over 1.8 million hospital admissions involving UTI’s in England, most of them in people aged 65 or over. 

Read more about the NHS Awareness Campaign to reduce the risk of UTI’s here: https://www.bmj.com/content/383/bmj.p2368. 

Similar Posts

  • ADI 2024

    The deadline for abstract submissions for Alzheimer’s Disease International conference 2024 in Krakow is Tuesday 10 October. Details at: https://adiconference.org/abstracts 

  • NICE publish final draft guidance on lecanemab and donanemab 

    Further to The National Institute for Health and Care Excellence (NICE) publishing draft guidance for public consultation about Alzheimer’s treatments donanemab and lecanemab (that we reported on here: https://journalofdementiacare.co.uk/nice-publish-further-draft-guidance-on-lecanemab-and-donanemab), NICE has published final draft guidance that continues to not recommend donanemab and lecanemab for use on the NHS.    Explaining the decision, Helen Knight, NICE Director…

  • Music in the care pathway

    Care provider Anchor has launched a dementia music therapy project with a university research unit to find out how best to include music in the care pathway. Funded by the Utley Foundation and conducted with Anglia Ruskin University’s Cambridge Institute for Music Therapy Research, the project will also upskill care workers in using music in…

  • Lifetime achievement

    Professor Tom Dening, former director of the Nottingham University Centre for Dementia, has won an award for lifetime achievement from the Royal College of Psychiatrists.  Accepting the Lifetime Achievement Ward in Older People’s Mental Health, Professor Dening said it was a “great honour”.  He added: “I have been a doctor for nearly 43 years, psychiatrist…

  • Safe and Found Online being trialled 

    Safe and Found Online (SAFO), a digital version of the Herbert Protocol, is being trialled by West Yorkshire Police, Greater Manchester Police and Cumbria Police.  The scheme is designed to help locate vulnerable individuals, particularly those living with dementia, if they go missing. SAFO allows carers or individuals with dementia to create a secure, up-to-date…